Cargando…
Targeting the anti-apoptotic Bcl-2 family proteins: machine learning virtual screening and biological evaluation of new small molecules
Bcl-2 family anti-apoptotic proteins are overexpressed in several hematological and solid tumors, and contribute to tumor formation, progression, and resistance to therapy. They represent a promising therapeutic avenue to explore for cancer treatment. Venetoclax, a Bcl-2 inhibitor is currently used...
Autores principales: | Valentini, Elisabetta, D'Aguanno, Simona, Di Martile, Marta, Montesano, Camilla, Ferraresi, Virginia, Patsilinakos, Alexandros, Sabatino, Manuela, Antonini, Lorenzo, Chiacchiarini, Martina, Valente, Sergio, Mai, Antonello, Colotti, Gianni, Ragno, Rino, Trisciuoglio, Daniela, Del Bufalo, Donatella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899577/ https://www.ncbi.nlm.nih.gov/pubmed/35265218 http://dx.doi.org/10.7150/thno.64233 |
Ejemplares similares
-
Antitumor effect of Melaleuca alternifolia essential oil and its main component terpinen-4-ol in combination with target therapy in melanoma models
por: Di Martile, Marta, et al.
Publicado: (2021) -
Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer
por: D’Aguanno, Simona, et al.
Publicado: (2020) -
Bcl-2 family inhibitors sensitize human cancer models to therapy
por: Valentini, Elisabetta, et al.
Publicado: (2023) -
SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
por: Valentini, Elisabetta, et al.
Publicado: (2021) -
BCL-X(L) overexpression promotes tumor progression-associated properties
por: Trisciuoglio, Daniela, et al.
Publicado: (2017)